Aurobindo Pharma

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue8,4068,8348,9709,41510,432
Expenses7,1327,4307,6777,8588,741
EBITDA1,7991,9611,8702,1452,324
EBIT1,3711,4311,3891,6171,790
Profit Before Tax1,2761,3391,2911,5151,688
Net Profit848.13909.80920.841,0321,124
Financial Ratios
Operating Profit Margin21.86%22.04%21.34%23.10%22.69%
Net Profit Margin10.30%11.10%10.53%11.60%11.01%
Earning Per Share (Diluted)14.6115.6715.8617.8619.57
Dividends Per Share0.000.000.000.007.00